533P Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours. - Bazhenova, L.; Liu, S.V.; Lin, J.J.; Lu, S.; Drilon, A.; Chawla, S.P.; Fakih, M.; Krzakowski, M.; Paz-Ares, L.; Blakely, C.; Buchschacher, G.L.; Cassier, P.; et al. (Annals of Oncology, 2021)